Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Swedish researchers focus on breast cancer risk

Swedish researchers are recruiting 100,000 women for KARMA (Karolinska mammogram project for identifying risk factors for breast cancer), a 10-year study of breast cancer risk factors.

NIH invests nearly $10M in preclinical cardioprotective therapy research

The National Institutes of Health's (NIH) National Heart, Lung and Blood Institute has awarded $9.56 million over five years to a University of Louisville Health Sciences Center research scientist to form a multicenter network examining cardioprotective therapies at the preclinical level.

Mayo sees $100M for proton beam therapy gift

The Mayo Clinic has received $100 million to help establish its multi-site Proton Beam Therapy Program.

NEJM: ACOs may pose challenge for academic medical centers

Because of the hierarchical structure of large academic medical centers, they will have difficulty moving toward an accountable care organization (ACO) model, and will need to adopt a more collaborative structure, according to an editorial published Feb. 2 in the New England Journal of Medicine.

Radiology: 175 exams yields sufficient CT colonography training

With CT colonography gaining acceptance as an alternative to colorectal cancer screening via colonoscopy, researchers have concluded that an average of 175 studies may amount to sufficient training for novice radiologists and technicians reading the images, according to a study published in the February issue of Radiology.

FDA panel recommends broadening indications for carotid stenting

The FDAs Circulatory System Devices Advisory Panel has recommended expanding the availability of carotid artery stenting to patients at standard risk for adverse events while undergoing surgery.

Spectrum applies for fewer doses for its lymphoma drug Zevalin

Biotech company Spectrum Pharmaceuticals has submitted a Post Approval Supplement to the FDA asking the agency to remove the bioscan requirement on the administration of its non-Hodgkin's lymphoma drug Zevalin.

FDA warns AngioDynamics on NanoKnife marketing

AngioDynamics has acknowledged receiving a warning letter from the FDA regarding certain aspects of the companys marketing program for its NanoKnife system.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.